The Ministry of Finance on March 23, 2021 has further amended the vide notification S.O. 1055 (E), dated October 19, 2001 which specify the quantity (small & commercial) in relation to narcotic drug or psychotropic substance under the Narcotic Drugs and Psychotropic Substances Act, 1985.
In the specified table, the following chemical name with the small & commercial quantity has been substituted, are as follows: -
• 238ZI- Methyl 1-(2-pheny lethyl)- 4- [phenyl(propnoyl)amino]pip eridine-4-carboxylate 0.00005 gm -0.001 gm
• 238 ZJ- N-(2-Fluorophenyl)-2- methoxy-N-[1-(2- phenylethyl)piperidin-4- l]acetamide 0.00217 gm- 0.0434 gm
• 238 ZK- N-Phenyl-N-[1-(2- phenylethyl)piperidin-4- y1]furan-2-carboxamide 0.02 gm- 1 gm
• 238 ZL- N-Phenyl-N-[1-(2- phenylethyl)piperidin-4- y1]prop-2-enamide 0.0025 gm- 0.125 gm
• 238 ZM- N-(4-Fluoropheny)-2- methyl-N-[1-(2- phenylethyl)piperidin-4- yl]propenamide; 0.03 gm- 1.5 gm
• 238 ZN- N-Phenyl-N-[1-(2- phenylethy)piperidin-4- yl]oxolane-2-carboxamide 0.005 gm- 0.1 gm
• 238 ZO- N-[(2S)-1-Amino-3-methyl1-oxobutan-2-yl]-1- (cyclohexylmethyl)-1Hindazole-3-carboxamide 0.05 gm- 2.5 gm
• 238 ZP Methyl(2S)-2-{1-(5- fluorophentyl)-1H-indazole3-carbonylamino}-3,3- dimethylbutanoate 0.005 gm -0.25 gm
• 238ZQ- N-[(2S)-1-Amino-3-methyl1oxobutan-2yl]-1-penty1Hindazole 3-carboxamide 0.0178 gm - 0.892 gm
• 238ZR- (1-Penty-1 H-indol-3- yl) (2,2,3,3- tetramrthylcyclopropyl)met hanone 0.05 gm - 2.5 gm
• 238ZS- Quinolin-8-yl 1-(5- fluropenthl)-1h-inodole-3- carboxylate 0.1 gm- 5.0 gm
• 238 ZT- 1-(4-Fluorophenyl) propan2-amine 2 gm -50 gm
• 238ZU- N-[(2S)-1-amino-3-methyl1-oxobutan-2-yl]-1- [(4- fluorophenyl) methyl] indazole-3- carboxamide - 0.025 gm -1.25 gm
• 238ZV- Methyl 2-({[1-(5- fluoropentyl)-1Hindazol3yl] carbonyl} amino)-3-methylbutanoate - 0.0027 gm- 0.135 gm
• 238ZW- Methyl(S)-2-(1-(5- fluoropentyl)-1H-indole-3- carboxamido)-3,3- dimethylbutanoate - 0.0050 gm -0.25 gm
• 238ZX- Methyl(S)-2-(1-(4- fluorobutyl)-1H-indazole-3- carboxamido)-3,3- dimethylbutanoate -0.0050 gm- 0.25 gm
• 238ZY- 1-(4-chlorophenyl)-2- (methylamino)-1- propanone - 5.0 gm- 250 gm
• 238ZZ- 2-(Ethylamino)-1-phenyl-1- hexanone - 1.0 gm- 50 gm
• 238ZZA- (RS)-1-Phenyl-2- (pyrrolidine-1-yl)hexan-1- one - 0.1 gm- 5.0 gm
• 238ZZB- 8-Chloro-6-(2-fluorophenyl)-1-methyl4hbenzo[f][1,2,4]triazolo[4, 3-a][1,4]diazepime - 0.0125 gm- 0.625 gm
• 238ZZC- 4-(2-Chlorophenyl)-2-ethyl9-methyl-6H-thieno[3,2- f][1,2,4]triazolo[4,3a][1,4]di azepine - 0.05 gm- 2.5 gm
• 238ZZD- 4-Chloro-2,5- dimethoxyamfetamine 0.15 gm- 7.5 gm
• 238ZZE- N-[(2S)-1-amino-3,3- dimethyl-1-oxobutan-2- yl]- 1-[(4-fluorophenyl)methyl]- 1Hindazole-3-carboxamide 0.01 gm- 0.5 gm
• 238ZZF- Methyl(2S)-2-({1-[4- fluorophenyl]methyl1Hindazole-3-carbonyl }amino)-3- methylbutanoate - 0.01 gm- 0.5 gm
• 238ZZG- 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)- 1Hindazole-3-carboxamide - 0.01 gm- 0.5 gm
• 238ZZH- N-[(2S)-1-amino-3,3- dimethyl-1-oxobutan-2- yl]- 1-(cyclohexylmethyl)-1Hindazole-3- carboxamide- 0.005 gm - 0.25 gm
• 238ZZI- 1-(2H-1,3-benzodioxol-5- yl)-2- (ethylamino)pentan1-one - 0.1 gm - 5 gm
• 238 ZZJ- (2E)-N-phenyl-N-[1-(2- phenylethyl)piperidin-4- yl]but-2-enamide -0.014 gm - 0.28 gm
• 238 ZZK- N-phenyl-N-[1-(2- phenylethyl)piperidin-4- yl]pentanamide - 0.40 gm - 8.0 gm
• 238 ZZL- N-(4-fluorophenyl)-N-[1-(2- phenylethyl) piperidin-4-yl] butanamide- 0.005 gm- 0.1 gm
• 238 ZZM- N-(2-fluorophenyl)-N-[1-(2- phenylethyl) piperidin-4-yl] propanamide. 0.005 gm- 0.1 gm
• 238 ZZN- 2-methoxy-N-phenyl-N-[1- (2-phenylethyl) piperidin-4- yl] acetamide- 0.005 gm- 0.1 gm
• 238 ZZO- N-Phenyl-N-[1-(2- phenylethyl) piperidin-4-yl] cyclopropane carboxamide - 0.005 gm -0.1 gm
[Notification No- S.O. 1276(E)]
